Alaven Pharmaceutical has made available sfRowasa (mesalamine), a sulfite-free rectal suspension for the treatment of active mild to moderate distal ulcerative colitis (UC), proctosigmoiditis, or proctitis. Previously, all mesalamine rectal suspension products contained the preservative potassium metabisulfite which converts to hydrogen sulfide and sulfuric acid when introduced in the colon. It has been demonstrated in a study that sulfite-containing products may exacerbate natural sulfide levels in the colon and may increase inflammation in UC patients.

sfRowasa is available in a 4g/60mL dosage strength.

For more information call (888) 317-0001 or visit www.alavenpharm.com.